Later development of inflammatory bowel disease in the healthy spouse of a patient
Kirsner, J.B.
New England Journal of Medicine 307(18): 1148
1982
ISSN/ISBN: 0028-4793 PMID: 7121534 Document Number: 189774
Document emailed within 1 workday
Related Documents
García López, S. 2008: Inflammatory bowel disease. If a patient with Crohn's disease remains in remission for 4 years with azathioprine (or mercaptopurine), should the drug be withdrawn? Gastroenterologia y Hepatologia 31(10): 704-705Gould, P.C.; Desai, H.P.; Bartolomeo, R.S.; Schwartz, G.J.; Swartz, L. 1992: Adrenal hemorrhage in a patient with inflammatory bowel disease treated with steroids New York State Journal of Medicine 92(12): 552-553
Asakura, H.; Sugimura, K. 1999: Present states of development in new drugs and treatment of inflammatory bowel disease Nihon Rinsho. Japanese Journal of Clinical Medicine 57(11): 2490-2495
Noskova, K.K.; Lishchinskaia, A.A.; Parfenov, A.I.; Kniazev, O.V.; Varvanina, G.G.; Drozdov, V.N. 2011: Risk of development of clinical and pathogenetic features of anemia on the background of basic therapy of inflammatory bowel disease Eksperimental'naia i Klinicheskaia Gastroenterologiia 10: 12-17
Schei, B. 1991: Physically abusive spouse--a risk factor of pelvic inflammatory disease? Scandinavian Journal of Primary Health Care 9(1): 41-45
Weiss, D.J.; Gagne, J.M.; Armstrong, P.J. 1996: Relationship between inflammatory hepatic disease and inflammatory bowel disease, pancreatitis, and nephritis in cats Journal of the American Veterinary Medical Association 209(6): 1114-1116
Silberer, H.; Küppers, B.; Mickisch, O.; Baniewicz, W.; Drescher, M.; Traber, L.; Kempf, A.; Schmidt-Gayk, H. 2005: Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome Clinical Laboratory 51(3-4): 117-126
Walker, E.A.; Katon, W.J.; Roy-Byrne, P.P.; Jemelka, R.P.; Russo, J. 1993: Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease American Journal of Psychiatry 150(10): 1502-1506
Brullet, E.; Bonfill, X.; Urrútia, G.; Ruiz Ochoa, V.; Cueto, M.; Clofent, J.; Martínez Salmerón, J.F.; Riera, J.; Obrador, A. 1998: Epidemiological study on the incidence of inflammatory bowel disease in 4 Spanish areas. Spanish Group on the Epidemiological Study of Inflammatory Bowel Disease Medicina Clinica 110(17): 651-656
Veljaca, M. 2001: Anti-inflammatory peptides and proteins in inflammatory bowel disease Current Opinion in Investigational Drugs 2(10): 1387-1394
Van Hees, P.A. 1981: Pharmacokinetics of Azulfidine/Salazopyrin in healthy humans and in patients with chronic inflammatory bowel diseases Zeitschrift für Gastroenterologie. Verhandlungsband 19: 7-14
King, J.A.; Underwood, F.E.; Panaccione, N.; Quan, J.; Windsor, J.W.; Kotze, P.G.; Ng, S.C.; Ghosh, S.; Lakatos, P.L.; Jess, T.; Panaccione, R.; Seow, C.H.; Ben-Horin, S.; Burisch, J.; Colombel, J.-F.éd.ér.; Loftus, E.V.; Gearry, R.; Halfvarson, J.; Kaplan, G.G. 2019: Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development LANCET. Gastroenterology and Hepatology 4(4): 287-295
Colin, R.; Lerebours, E. 1991: Inflammatory bowel diseases in adults. Development and complications La Revue du Praticien 41(5): 419
Kirsner, J.B. 1999: "Nonspecific" inflammatory bowel disease (ulcerative colitis and Crohn's disease) after 100 years--what next? Italian Journal of Gastroenterology and Hepatology 31(8): 651-658
Akolkar, P.N.; Gulwani-Akolkar, B.; Heresbach, D.; Lin, X.Y.; Fisher, S.; Katz, S.; Silver, J. 1997: Differences in risk of Crohn's disease in offspring of mothers and fathers with inflammatory bowel disease American Journal of Gastroenterology 92(12): 2241-2244
Gushchin, S.V.; Rumiantsev, V.G.; Marilov, V.V. 2006: Role of psychosocial factors in the development and course of inflammatory bowel diseases Eksperimental'naia i Klinicheskaia Gastroenterologiia 6: 84-91
Becker, K.; Niederau, C.; Frieling, T. 1999: Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease Zeitschrift für Gastroenterologie 37(7): 597-605
Krawiec, P.; Pawłowska-Kamieniak, A.; Pac-Kożuchowska, E.żb.; Mroczkowska-Juchkiewcz, A.; Kominek, K. 2016: Coexistence of coeliac disease and inflammatory bowel disease in children Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 40(235): 53-55
Pawłowska, K.; Iwańczak, B. 2014: Somatic development disorders of children with non specific inflammatory bowel diseases Developmental Period Medicine 18(3): 323-330
Stenson, W.F.; MacDermott, R.P. 1989: Immunology of inflammatory bowel disease Year in Immunology 4: 286-295